AMEDMENT NO. 2 TO CONTRACT ON CLINICAL TRIALContract on Clinical Trial • August 29th, 2018
Amendment No. 2 to Contract on Clinical TrialContract on Clinical Trial • August 22nd, 2018
Krajská zdravotní, a.s., having a place of business at Sociální péče 3316/12A, 401 13 Ústí nad Labem, Czech Republic, Identification number: 254 88 627, Tax identification number: CZ25488627, represented by Petr Fiala, managing director
AMEDMENT NO. 1 TO CONTRACT ON CLINICAL TRIALContract on Clinical Trial • November 3rd, 2017
ContractContract on Clinical Trial • April 20th, 2018
AMENDMENT NO. 1 TO THE CONTRACT ON CLINICAL TRIAL This Amendment No. 1 to the Contract on Clinical Trial (Hereinafter referred to as the „Amendment No. 1“) is between F. Hoffmann-La Roche Ltdhaving a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland, represented by Quintiles Czech Republic, s.r.o.(Hereinafter referred to as the „Sponsor“) andContractual research organization Quintiles Czech Republic, s.r.o.having a place of business at Radlická 714/113a, Jinonice, 158 00 Praha 5, Czech RepublicIdentification number: 247 68 651Tax Identification number: CZ247 68 651 (Hereinafter referred to as the „Contractual research organization“) and Všeobecná fakultní nemocnice v PrazeU Nemocnice 499/2, 128 08 Praha 2, Czech RepublicIdentification No: 00064165 VAT No.: CZ00064165represented by Mgr. Dana Jurásková, Ph.D., MBA (Hereinafter referred to as the “Medical Service Provider” or “Provider”’) and Date of birth:Address:(Hereinafter referred to as the “Principal Investigator“)
Amendment No. 1 to Contract on Clinical TrialContract on Clinical Trial • March 8th, 2017
Fakultní nemocnice Hradec Králové, having a place of business at Sokolská 5Ř1, 500 05 Hradec Králové – Nový Hradec Králové, Identification number: 00179906, Tax identification number: CZ00179906¨, represented by prof. MUDr. Roman Prymula, CSc., Ph.D., director, bank coordinates: Česká spořitelna a.s., Praha, account number: 6256082/0800, variable symbol: invoice number (Hereinafter referred to as the ‘Medical Facility’)
ContractContract on Clinical Trial • March 3rd, 2021
Amendment No. 4 to Contract on Clinical TrialThis Amendment to Contract on Clinical Trial (“Amendment No. 4”) is between: ABBVIE DEUTSCHLAND GMBH & CO.KG,having a place of business at Max-Planck-Ring 2a, 65205 Wiesbaden, represented by AbbVie s.r.o., Metronom Business Center, Bucharova 2817/13, Stodůlky, 158 00 Praha 5, Czech Republic (‘Sponsor’) andF. HOFFMANN-LA ROCHE LTD, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (‘Roche’),represented upon power of attorney given to:IQVIA RDS Czech Republic s.r.o., Pernerova 691/42,186 00 Prague 8, Karlín, Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651and IQVIA RDS Czech Republic s.r.o. having a place of business at Pernerova 691/42, 186 00 Prague 8, Karlín,Czech Republic, Identification number: 247 68 651,Tax Identification number: CZ247 68 651 (‘Contractual research organization’ or ‘IQVIA’), and Fakultní nemocnice Ostrava, having place of business at 17. Listopadu 1790
Amendment No. 8 to Contract on Clinical TrialContract on Clinical Trial • April 30th, 2019
ContractContract on Clinical Trial • July 16th, 2018
Amendment No. 2 to Contract on Clinical Trial concluded on 10. 11. 2014 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerlandrepresented by IQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Prague 8,Karlín, Czech Republic(Hereinafter referred to as the ‘Sponsor’) andContractual research organizationIQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Prague 8, Karlín,Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651, formerly Quintiles Czech Republic, s.r.o.(Hereinafter referred to as the ‘Contractual research organization’) and Thomayerova nemocnice, having a place of business at Vídeňská 800, 140 59 Praha 4, Czech Republic,Identification number: 000 64 190, Tax identification number: CZ00064190, state contributory organization established by the Ministry of Health of the Czech Republic, full text of foundat
ContractContract on Clinical Trial • November 23rd, 2018
AMENDMENT NO. 1 TO THE CONTRACT ON CLINICAL TRIAL This Amendment No. 1 to the Contract on Clinical Trial (Hereinafter referred to as the „Amendment No. 1“) is between F. Hoffmann-La Roche Ltd.having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland, represented by IQVIA RDS Czech Republic, s.r.o. (Hereinafter referred to as the “Sponsor”) and Contractual research organization IQVIA RDS Czech Republic, s.r.o.having a place of business at Pernerova 691/42, 186 00 Praha 8, Czech RepublicIdentification number: 247 68 651Tax Identification number: CZ247 68 651(Hereinafter referred to as the “Contractual research organization”) and Masarykův onkologický ústavhaving a place of business at Žlutý kopec 7, 656 53 Brno, Czech RepublicIdentification number: 002 09 805Tax Identification number: CZ002 09 805represented by prof. MUDr. Jan Žaloudík, CSc., director(Hereinafter referred to as the “Health service provider”) and with an address date of birth:(Hereinafter referred to as
Amendment No. 2 to Contract on Clinical TrialContract on Clinical Trial • February 13th, 2017
ContractContract on Clinical Trial • December 3rd, 2018
AMEDMENT NO. 1 TO CONTRACT ON CLINICAL TRIAL This Amendment to Contract on Clinical Trial (“Amendment”) is made by and between: F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland, represented by IQVIA RDS Czech Republic s.r.o., (Hereinafter referred to as the ‘Sponsor’), and Contractual research organization IQVIA RDS Czech Republic, s.r.o. (formerly Quintiles Czech Republic, s.r.o.), represented by, having a place of business at Praha 8, Pernerova 691/42, zip code 186 00, Czech Republic, Identification number: 24768 651, Tax Identification number: CZ247 68 651, (Hereinafter referred to as the ‘Contractual research organization’), and Oblastní nemocnice Kladno, a.s., nemocnice Středočeského kraje, having a place of business at Vančurova 1548, postcode 27259 Kladno, Czech Republic, Identification number: 272 56 537, Tax identification number: CZ27256 537, represented by ,and , (Hereinafterreferred to as the ‘Medical Facility’), and, ha
ContractContract on Clinical Trial • August 20th, 2018
Amendment No. 3 to Contract on Clinical Trial concluded on 26. 11. 2014 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerlandrepresented by IQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Prague 8, Karlín, Czech Republic (Hereinafter referred to as the ‘Sponsor’)and Contractual research organizationIQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Prague 8, Karlín,Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651, formerly Quintiles Czech Republic, s.r.o.(Hereinafter referred to as the ‘Contractual research organization’) and Krajská nemocnice T. Bati, a. s., having a place of business at Havlíčkovo nábřeží 600, 762 75 Zlín, Czech Republic, Identification number: 27661989, Tax identification number: CZ27661989, represented by MUDr. Radomír Maráček, Chairman of the Board of Directors, and Ing. Vlastimil V
Dodatek č. 3 ke SmlouvěContract on Clinical Trial • August 20th, 2024
ContractContract on Clinical Trial • September 20th, 2016
Amendment No. 1 to Contract on Clinical Trial concluded on 26. 11. 2014 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland represented by Quintiles Czech Republic s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, Czech Republic (Hereinafter referred to as the ‘Sponsor’) and Contractual research organization Quintiles Czech Republic, s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651 (Hereinafter referred to as the ‘Contractual research organization’) and Krajská nemocnice T. Bati, a. s., having a place of business at Havlíčkovo nábřeží 600, 762 75 Zlín, Czech Republic, Identification number: 276 61 989, Tax identification number: CZ27661989, represented by Ing. Pavel Calábek, Chairman of the Board of Directors and MUDr. Marcel Guřan, Member of the Board of Directors, reg
ContractContract on Clinical Trial • June 25th, 2018
Amendment No. 2 to Contract on Clinical Trial concluded on 20. 01. 2015 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerlandrepresented by IQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Prague 8,Karlín, Czech Republic(Hereinafter referred to as the ‘Sponsor’) andContractual research organizationIQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Prague 8, Karlín,Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651, formerly Quintiles Czech Republic, s.r.o.(Hereinafter referred to as the ‘Contractual research organization’) and Nemocnice Na Bulovce, having a place of business at Budínova 67/2, 180 81 Praha 8, Czech Republic, Identification number: 00064211, Tax identification number: CZ00064211, represented by MUDr. Hana Roháčová, Ph.D., Deputy Director for medical and preventive care, based on its authorisa
ContractContract on Clinical Trial • October 26th, 2016
Amendment No. 1 to Contract on Clinical Trial concluded on 24. 08. 2015 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (Hereinafter referred to as the ‘Sponsor’) and Contractual research organizationQuintiles Czech Republic, s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, CzechRepublic, Identification number: 247 68 651, TaxIdentification number: CZ247 68 651(Hereinafter referred to as the ‘Contractual research organization’) and Fakultní nemocnice Královské Vinohrady, having a place of business at Šrobárova 1150/50, 100 34 Prague 10, Czech Republic, Identification number: 00064173, Tax identification number: CZ00064173, represented by Doc. MUDr. Robertem Grill, PhD., MHA, Director, reference symbol KH 52/2014, internal cost center no. 22037 (Hereinafter referred to as the ‘Medical Facility’) PreambleWHEREAS: A. The Parties have concluded on 24. 08. 2015 the Contract on Clinical Trial, (here
ContractContract on Clinical Trial • August 30th, 2018
Amendment No. 1 to Contract on Clinical Trial concluded on 22.8.2017 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland represented by IQVIA RDS Czech Republic s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8,Czech Republic(Hereinafter referred to as the ‘Sponsor’) andContractual research organization IQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8, CzechRepublic, Identification number: 247 68 651, TaxIdentification number: CZ247 68 651(Hereinafter referred to as the ‘Contractual research organization’) And Fakultní nemocnice u sv. Anny v Brněhaving a place of business at Pekařská 664/53, 656 91 Brno, Czech Republic, Identification number: 00159816, Tax identification number: CZ00159816, represented by MUDr. Martin Pavlík, Ph.D., DESA, EDIC, Director(Hereinafter referred to as the ‘Medical Facility’) and ( ) Preamble WHEREAS: A. The Parties have conc
ContractContract on Clinical Trial • November 25th, 2020
AMEDMENT NO. 5 TO CONTRACT ON CLINICAL TRIAL This Amendment No. 5 to Contract on Clinical Trial („Amendment“) between: F. Hoffmann-La Roche Ltd,having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland(Hereinafter referred to as the ‘Sponsor’) represented upon power of attorney given to: IQVIA Czech Republic, s.r.o.having a place of business Pernerova 691/42, Karlín, 186 00 Praha 8, Czech RepublicIdentification number: 247 68 651Tax Identification number: CZ247 68 651 andContractual research organizationIQVIA Czech Republic, s.r.o.having a place of business at Pernerova 691/42, Karlín, 186 00 Praha 8, Czech RepublicIdentification number: 247 68 651Tax Identification number: CZ247 68 651(Hereinafter referred to as the ‘Contractual research organization’) and Krajská zdravotní, a.s.having a place of business at Sociální péče 3316/12A, 401 13, Ústí nad Labem, Czech Republic Identification number: 254 88 627,Tax Identification number: CZ25488627, represented by Ing. Petr
ContractContract on Clinical Trial • October 19th, 2017
Amendment No. 1 to Contract on Clinical Trial concluded on 07. 10. 2014 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerlandrepresented by Quintiles Czech Republic s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5,Czech Republic(Hereinafter referred to as the ‘Sponsor’) and Quintiles Czech Republic, s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, CzechRepublic, Identification number: 247 68 651, TaxIdentification number: CZ247 68 651(Hereinafter referred to as the ‘Contractual research organization’) and Thomayerova nemocnice, having a place of business at Vídeňská 800, 140 59 Praha 4 – Krč, Identificationnumber: 000 64 190, Tax identification number: CZ000 64 190, state contributory organization established by the Ministry of Health of the Czech Republic, full text of foundation deed No. MZDR 17268-IV/2012, registered in Companies Registry by Municipal Court in Prague, Secti
ContractContract on Clinical Trial • November 20th, 2018
Amendment No. 2 to Contract on Clinical Trial concluded on 19. 12. 2014 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerlandrepresented by IQVIA RDS Czech Republic s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8,Czech Republic(Hereinafter referred to as the ‘Sponsor’) andContractual research organizationIQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Praha 8, CzechRepublic, Identification number: 247 68 651, TaxIdentification number: CZ247 68 651(Hereinafter referred to as the ‘Contractual research organization’) andKrajská nemocnice T. Bati, a. s., having a place of business at Havlíčkovo nábřeží 600, 762 75 Zlín, CzechRepublic, Identification number: 276 61 989, Tax identification number: CZ27661989, ,registered in Companies Registry by Regional Court in Brno, Section B, inlet 4437(Hereinafter referred to as the ‘Medical Facility’) and(Hereinafter referred
ContractContract on Clinical Trial • February 1st, 2019
AMENDMENT 2 TO CONTRACT ON CLINICAL TRIAL DODATEK Č. 2 KE SMLOUVĚ O KLINICKÉM HODNOCENÍ This Amendment 2 to Contract On Clinical Trial (“Amendment”) is between IQVIA RDS Czech Republic, s.r.o., with its seat at Pernerova 691/42, 186 00 Pague 8 - Karlín, Czech Republic (“IQVIA” and/or “Contractual Research Organization” or “CRO”), Masarykův onkologický ústav, having a place of business at Ţlutý kopec 7, Brno, zip code 656 53, Czech Republic (the “Provider”), Astra Zeneca AB, having a place of business at 151 85 Sӧdertӓlje, Sweden, SE-151 85 (the “Sponsor” and/or “Astra Zeneca”) and, an of the Provider, with the address at(the “Principal Investigator”) each a “Party” and together the “Parties” and is effective as of the date last signed below. Tento dodatek č. 2 ke smlouvě o klinickém hodnocení (dále jen „Dodatek“) se uzavírá mezi společností IQVIA RDS Czech Republic, s.r.o., se sídlem Pernerova 691/42,186 00 Praha 8 – Karlín, Česká republika (dále jen „společnost IQVIA“ a/nebo„s
Amendment No. 2 to Contract on Clinical Trial concluded on 23.02.2016 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (Hereinafter referred to as the ‘Sponsor’) and Contractual...Contract on Clinical Trial • August 1st, 2018
The Parties agreed on the following changes in the Article XIII. “Financial aspects”, Paragraph 2. “ ”, of the Agreement: 1. The Paragraph 2. “ ” of the ArticleXIII. “Financial aspects” of the Agreement is deleted and replaced as follows: Strany se dohodly na následujících změnách v ČlánkuXIII. “Finanční aspekty”, Odstavci 2. “ ”, Smlouvy: 1. Odstavec 2. „ “ Článku XIII. “Finanční aspekty”, Smlouvy se ruší a nahrazuje následujícím zněním:
ContractContract on Clinical Trial • August 17th, 2017
Amendment No. 2 to Contract on Clinical Trial concluded on 5. 6. 2013 between Dodatek č. 2 ke Smlouvě o klinickém hodnocení uzavřené 5. 6. 2013 mezi F. Hoffmann-La Roche Ltd.having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland(Hereinafter referred to as the ‘Sponsor’) represented upon power of attorney given to: Quintiles Czech Republic, s.r.o.with its seat at Radlická 714, 158 00 Praha 5, Czech RepublicIdentification number: 247 68 651Tax identification number: CZ247 68 651 andContractual research organization Quintiles Czech Republic, s.r.o.having a place of business at Radlická 714, 158 00 Praha 5, Czech RepublicIdentification number: 247 68 651Tax Identification number: CZ247 68 651(Hereinafter referred to as the ‘Contractual research organization’) and Masarykův onkologický ústavhaving a place of business Žlutý kopec 7, 656 53 Brno, Czech RepublicIdentification number: 00209805, Tax identification number: CZ00209805Bank coordinates: Česká národní banka.,Act
ContractContract on Clinical Trial • December 9th, 2016
Amendment No. 1 to Contract on Clinical Trial concluded on 25.08.2015 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (Hereinafter referred to as the ‘Sponsor’) and Contractual research organizationQuintiles Czech Republic, s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, CzechRepublic, Identification number: 247 68 651, TaxIdentification number: CZ247 68 651(Hereinafter referred to as the ‘Contractual research organization’) and Fakultní nemocnice u sv. Anny v Brně, having a place of business at Pekařská 664/53, 656 91 Brno, Czech Republic, Identification number: 00159816, Tax identification number: CZ00159816, represented by MUDr. Martin Pavlík, Ph.D., DESA, EDIC, director (Hereinafter referred to as the ‘Medical Facility’) and , address: , date ofbirth:(Hereinafter referred to as the “Principal Investigator“) Preamble WHEREAS:A. The Parties have concluded on 25.08.2015 the Contract on Clini
ContractContract on Clinical Trial • March 7th, 2017
Amendment No. 1 to Contract on Clinical TrialReg. No.: 08/OVZ/15/039-P concluded on 20. 08. 2015 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (Hereinafter referred to as the ‘Sponsor’) and Contractual research organizationQuintiles Czech Republic, s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, CzechRepublic, Identification number: 247 68 651, TaxIdentification number: CZ247 68 651(Hereinafter referred to as the ‘Contractual research organization’) and Fakultní nemocnice Ostrava, having a place of business at 17. listopadu 1790/5, Ostrava – Poruba, postcode 708 52, Czech Republic, Identification number 008 43 989, Tax identification number CZ00843989, Founding document of the Ministry of Health of the Czech Republic dated of November 25th, 1990, ref. No. OP-054-25.11.90 with regard to this Agreement the following representative is authorised to act on behalf of Institution and to execute t
ContractContract on Clinical Trial • July 25th, 2017
AMENDMENT 1 TO CONTRACT ON CLINICAL TRIAL DODATEK Č. 1 KE SMLOUVĚ O KLINICKÉM HODNOCENÍ This Amendment 1 to Contract On Clinical Trial (“Amendment”) is between Quintiles Czech Republic, s.r.o., with its seat at Radlická 714, 158 00 Praha 5, Czech Republic (“Quintiles” and/or “Contractual Research Organization” or “CRO”), Masarykůvonkologickýústav, having a place of business at Žlutýkopec 7, Brno, zip code 656 53, Czech Republic (the “Provider”), Astra Zeneca AB, having a place of business at 15185 Sӧdertӓlje, Sweden, SE-151 85 (the “Sponsor” and/or “Astra Zeneca”) and, an employee of the Provider, with the address at (the “Principal Investigator”), each a “Party” andtogether the “Parties” and is effective as of the date last signed below. Tento dodatek č. 1 ke smlouvě o klinickém hodnocení („Dodatek“) se uzavírá mezi Quintiles Czech Republic, s.r.o., se sídlem Radlická 714, 158 00 Praha 5, Česká republika („Quintiles“ nebo „smluvní výzkumná organizace“ nebo „CRO“), Masarykovým onko
ContractContract on Clinical Trial • April 2nd, 2017
AMEDMENT NO. 1 TO CONTRACT ON CLINICAL TRIAL This Amendment to Contract on Clinical Trial (“Amendment”) is made by and between: F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland, represented by Quintiles Czech Republic s.r.o., (Hereinafter referred to as the ‘Sponsor’), and Contractual research organization Quintiles Czech Republic, s.r.o., having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00, Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651, (Hereinafter referred to as the ‘Contractual research organization’), and Městská nemocnice Ostrava, allowance organization, having a place of business at Nemocniční 898/20A, postcode 728 80 Ostrava, Czech Republic, Identification number: 00635162, Tax identification number: CZ00635162, represented by MUDr. Petr Uhlig, director of Městská nemocnice Ostrava, (Hereinafter referred to as the ‘Medical Facility’) and is valid as
ContractContract on Clinical Trial • May 23rd, 2018
AMENDMENT NO. 1 TO THE CONTRACT ON CLINICAL TRIAL This Amendment No. 1 to the Contract on Clinical Trial (Hereinafter referred to as the „Amendment No. 1“) is between F. Hoffmann-La Roche Ltd.having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland, represented by Quintiles Czech Republic, s.r.o.(Hereinafter referred to as the “Sponsor”) andContractual research organization Quintiles Czech Republic, s.r.o.having a place of business at Radlická 714/113a, Jinonice, 158 00 Praha 5, Czech RepublicIdentification number: 247 68 651Tax Identification number: CZ247 68 651(Hereinafter referred to as the “Contractual research organization”) and Masarykův onkologický ústavhaving a place of business at Žlutý kopec 7, 656 53 Brno, Czech RepublicIdentification number: 002 09 805Tax Identification number: CZ002 09 805represented by prof. MUDr. Jan Žaloudík, CSc., director (Hereinafter referred to as the “Health service provider”) and with an address date of birth:(Hereinafter refe
ContractContract on Clinical Trial • September 15th, 2016
Amendment No. 1 to Contract on Clinical Trial concluded on 19. 12. 2014 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland represented by Quintiles Czech Republic s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, Czech Republic (Hereinafter referred to as the ‘Sponsor’) and Contractual research organization Quintiles Czech Republic, s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651 (Hereinafter referred to as the ‘Contractual research organization’) and Krajská nemocnice T. Bati, a. s., having a place of business at Havlíčkovo nábřeží 600, 762 75 Zlín, Czech Republic, Identification number: 276 61 989, Tax identification number: CZ27661989, represented by Ing. Pavel Calábek, Chairman of the Board of Directors and MUDr. Marcel Guřan, Member of the Board of Directors, reg
ContractContract on Clinical Trial • April 2nd, 2017
AMEDMENT NO. 1 TO CONTRACT ON CLINICAL TRIAL This Amendment to Contract on Clinical Trial (“Amendment”) is made by and between: F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland, represented by Quintiles Czech Republic s.r.o., (Hereinafter referred to as the ‘Sponsor’), and Contractual research organization Quintiles Czech Republic, s.r.o., having a place of business at Praha 5, Jinonice, Radlická 714/113a, zip code 158 00, Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651, (Hereinafter referred to as the ‘Contractual research organization’), and Městská nemocnice Ostrava, allowance organization, having a place of business at Nemocniční 898/20A, postcode 728 80 Ostrava, Czech Republic, Identification number: 00635162, Tax identification number: CZ00635162, represented by MUDr. Petr Uhlig, director of Městská nemocnice Ostrava, (Hereinafter referred to as the ‘Medical Facility’) and is valid as
ContractContract on Clinical Trial • April 4th, 2017
Amendment No. 1 to Contract on Clinical Trial concluded on 24.08.2015 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland (Hereinafter referred to as the ‘Sponsor’) and Contractual research organizationQuintiles Czech Republic, s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, CzechRepublic, Identification number: 247 68 651, TaxIdentification number: CZ247 68 651(Hereinafter referred to as the ‘Contractual research organization’) and Fakultní nemocnice Královské Vinohrady, having a place of business at Šrobárova 1150/50, 100 34 Praha 10, Czech Republic, Identification number: 00064173, Tax identification number: CZ00064173, represented by doc. MUDr. Robert Grill, Ph.D., MHA, Director, reference symbol KH 18/2015, internal cost center no. 22044 (Hereinafter referred to as the ‘Medical Facility’) PreambleWHEREAS: 1. The Parties have concluded on 24. 08. 2015 the Contract on Clinical Trial, (hereinaf
AMEDMENT NO. 1 TO CONTRACT ON CLINICAL TRIALContract on Clinical Trial • February 6th, 2018
ContractContract on Clinical Trial • January 16th, 2018
Amendment No. 2 to Contract on Clinical Trial concluded on 26. 11. 2014 by and between F. Hoffmann-La Roche Ltd, having a place of business at Grenzacherstrasse 124, 4070 Basel, Switzerland represented by Quintiles Czech Republic s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, Czech Republic (Hereinafter referred to as the ‘Sponsor’) and Contractual research organization Quintiles Czech Republic, s.r.o., having a place of business at Radlická 714/113a, 158 00 Praha 5, Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651 (Hereinafter referred to as the ‘Contractual research organization’) and Krajská nemocnice T. Bati, a. s., having a place of business at Havlíčkovo nábřeží 600, 762 75 Zlín, Czech Republic, Identification number: 27661989, Tax identification number: CZ27661989, represented by MUDr. Radomír Maráček, Chairman of the Board of Directors and Ing. Vlastimil Vajdák, Member of the Board of Directors,
Amendment No. 3 to Contract on Clinical TrialContract on Clinical Trial • March 13th, 2020
having a place of business at Max-Planck-Ring 2a, 65205 Wiesbaden, represented by AbbVie s.r.o., Hadovka Office Park, Evropská 2591/33d, 160 00 Praha 6, Czech Republic (‘Sponsor’)
Amendment No. 2 to Contract on Clinical TrialContract on Clinical Trial • July 23rd, 2018
IQVIA RDS Czech Republic, s.r.o., having a place of business at Pernerova 691/42, 186 00 Prague 8, Karlín, Czech Republic, Identification number: 247 68 651, Tax Identification number: CZ247 68 651, formerly Quintiles Czech Republic, s.r.o. (Hereinafter referred to as the ‘Contractual research organization’)
